Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates
Carolina Berger, … , Carole Elliott, Stanley R. Riddell
Carolina Berger, … , Carole Elliott, Stanley R. Riddell
Published December 3, 2007
Citation Information: J Clin Invest. 2008;118(1):294-305. https://doi.org/10.1172/JCI32103.
View: Text | PDF
Research Article Immunology

Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates

  • Text
  • PDF
Abstract

The adoptive transfer of antigen-specific T cells that have been expanded ex vivo is being actively pursued to treat infections and malignancy in humans. The T cell populations that are available for adoptive immunotherapy include both effector memory and central memory cells, and these differ in phenotype, function, and homing. The efficacy of adoptive immunotherapy requires that transferred T cells persist in vivo, but identifying T cells that can reproducibly survive in vivo after they have been numerically expanded by in vitro culture has proven difficult. Here we show that in macaques, antigen-specific CD8+ T cell clones derived from central memory T cells, but not effector memory T cells, persisted long-term in vivo, reacquired phenotypic and functional properties of memory T cells, and occupied memory T cell niches. These results demonstrate that clonally derived CD8+ T cells isolated from central memory T cells are distinct from those derived from effector memory T cells and retain an intrinsic capacity that enables them to survive after adoptive transfer and revert to the memory cell pool. These results could have significant implications for the selection of T cells to expand or to engineer for adoptive immunotherapy of human infections or malignancy.

Authors

Carolina Berger, Michael C. Jensen, Peter M. Lansdorp, Mike Gough, Carole Elliott, Stanley R. Riddell

×

Figure 8

Adoptively transferred T cells expand in vivo to antigen stimulation.

Options: View larger image (or click on image) Download as PowerPoint
Adoptively transferred T cells expand in vivo to antigen stimulation.
(A...
(A) T-APCs pulsed with IE peptide are lysed by IE-specific CD8+ T cells. T-APCs generated from macaque A99171 were pulsed with peptide (filled squares) or media alone (open squares), labeled with 51Chromium, and used as targets for the autologous IE-specific CD8+ T cell clone that was used for adoptive transfer. (B) Expansion of endogenous and transferred CMV-specific T cells by infusion of T-APCs. A dose of 1 × 107 T-APCs/kg was administered to macaque A99171 nine weeks after infusion of a CD19+ TCM-derived clone. The number of CD3+CD8+ T cells and CD19+CD8+ T cells/μl of blood was measured by flow cytometry prior to and on indicated days following the T-APC administration. The number of endogenous IE-specific CD8+ T cells was measured by cytokine flow cytometry at the same time points after gating on CD19–CD3+CD8+ cells. The data show the fold increase in the absolute numbers of CD3+CD8+ T cells (white bars), CD19+CD8+ T cells (gray bars), and CD19– IE-specific CD8+ T cells (black bars) after the T-APC infusion.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts